News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Biagio Ricciuti: Mechanisms of acquired resistance to PD-(L)1 blockade in NSCLC
Photo taken from Biagio Ricciuti/LinkedIn
Jan 18, 2024, 15:55

Biagio Ricciuti: Mechanisms of acquired resistance to PD-(L)1 blockade in NSCLC

Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on LinkedIn:
“Now out in the Journal of Clinical Oncology our effort to elucidate mechanisms of acquired resistance to PD-(L)1 blockade in NSCLC. We identified acquired genomic and immunophenotypic changes that may contribute to the development of resistance to ICI +/- chemotherapy in patients with lung cancer.”
Biagio Ricciuti: Mechanisms of acquired resistance to PD-(L)1 blockade in NSCLC

Additional information.

Biagio Ricciuti cancer Journal of Clinical Oncology Lung cancer NSCLC OncoDaily Oncology
Special Coverage
Insight
Nov 21, 2024, 18:03
Jasmine Kamboje: Honored to be on the ballot for Community seat for the ASCO Nominating Committee
Blog
Nov 21, 2024, 17:57
Amy C. Moore: 20 years of progress in research and treatment in NSCLC
Blog
Nov 21, 2024, 17:54
Penilla Gunther: A rich day in Brussels
Insight
Nov 21, 2024, 17:44
E. Shyam P. Reddy: New study by Northwestern Medicine Canning Thoracic Institute revealed a connection between COVID-19 and cancer regression
Blog
Nov 21, 2024, 17:42
Margaret Foti: Thrilled to be at the Winn Diversity in Clinical Trials - Design and Implementation of Clinical Trials Workshop
Insight
Nov 21, 2024, 17:41
Aaron Goodman summarising a clinical case of Primary Cutaneous Follicular-Center lymphoma
Insight
Nov 21, 2024, 17:24
Harenthri Devy Alagir Rajah: Our abstract was honoured with the Vanessa Moss 10 Top Award at LGCW
Blog
Nov 21, 2024, 17:22
Early detection saves lives - IASLC
Insight
Nov 21, 2024, 17:20
Elisa Agostinetto: Young Cancer Professionals meeting at the European Cancer Summit
Insight
Nov 21, 2024, 17:14
Mieke Van Hemelrijck: United Against Cancer, Forging New Frontiers
Insight
Nov 21, 2024, 17:05
Sofiat Akinola: Investing in the elimination of cervical cancer, when funding is lacking
Insight
Nov 21, 2024, 16:56
Overview and clarification of the current HR+ HER2- EBC treatment landscape - SPCC